How to buy Quest Diagnostics Incorporated (DGX) shares in the UK

Learn how to easily invest in Quest Diagnostics Incorporated shares.

Quest Diagnostics Incorporated (DGX) is a leading diagnostics and research business based in the US. In the week up to 18 January Quest Diagnostics Incorporated shares plunged 12.07% to a closing position of $138.83. However, over the last 12 months, Quest Diagnostics Incorporated's share price has risen by 8.50% from $124.46. Quest Diagnostics Incorporated is listed on the NYSE and employs 50,000 staff. All prices are listed in US Dollars.

How to buy shares in Quest Diagnostics Incorporated

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: DGX in this case.
  5. Research Quest Diagnostics Incorporated shares. The platform should provide the latest information available.
  6. Buy your Quest Diagnostics Incorporated shares. It's that simple.
The whole process can take as little as 15 minutes.

Fees for buying 5x Quest Diagnostics Incorporated shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £2.51
£503.84 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.25
£502.59 total
Capital at risk
Stake logo £0 £50 £2.51
£503.84 total
Capital at risk
IG Share Dealing logo £0 £250 £9.97
£511.30 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £16.96
£518.30 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £15.51
£516.85 total
Capital at risk
Fineco logo £0 No minimum £5.01
£506.35 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £15.77
£517.10 total
Capital at risk

Full comparison of share dealing platforms

Quest Diagnostics Incorporated share price (NYSE:DGX)

Use our graph to track the performance of DGX stocks over time.

Is it a good time to buy Quest Diagnostics Incorporated stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

eToro Free Stocks

Invest in Quest Diagnostics Incorporated shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes
Capital at risk

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Quest Diagnostics Incorporated under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

Quest Diagnostics Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Quest Diagnostics Incorporated shares trade at around 9x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

PEG ratio

Quest Diagnostics Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 40.1904. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Quest Diagnostics Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.


Quest Diagnostics Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $3.1 billion (£2.3 billion).

The EBITDA is a measure of a Quest Diagnostics Incorporated's overall financial performance and is widely used to measure a its profitability.

How has coronavirus impacted Quest Diagnostics Incorporated's share price?

Since the stock market crash that started in February 2020, Quest Diagnostics Incorporated's share price has had significant positive movement.

Its last market close was $137.72, which is 17.84% up on its pre-crash value of $113.15 and 88.12% up on the lowest point reached during the March 2020 crash when the shares fell as low as $73.21.

If you had bought $1,000 worth of Quest Diagnostics Incorporated shares at the start of February 2020, those shares would have been worth $671.75 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,231.22.

Environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Quest Diagnostics Incorporated.

Total ESG risk score

Quest Diagnostics Incorporated's total ESG risk: 18.33

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Quest Diagnostics Incorporated's overall score of 18.33 (as at 01/01/2019) is excellent – landing it in it in the 16th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Quest Diagnostics Incorporated is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Environmental score

Quest Diagnostics Incorporated's environmental score: 0.86/100

Quest Diagnostics Incorporated's environmental score of 0.86 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Social score

Quest Diagnostics Incorporated's social score: 10.42/100

Quest Diagnostics Incorporated's social score of 10.42 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Governance score

Quest Diagnostics Incorporated's governance score: 5.77/100

Quest Diagnostics Incorporated's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Controversy score

Quest Diagnostics Incorporated's controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Quest Diagnostics Incorporated scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Quest Diagnostics Incorporated hasn't always managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Quest Diagnostics Incorporated was last rated for ESG on: 2019-01-01.

Total ESG score 18.33
Total ESG percentile 16.26
Environmental score 0.86
Environmental score percentile 1
Social score 10.42
Social score percentile 1
Governance score 5.77
Governance score percentile 1
Level of controversy 3

Quest Diagnostics Incorporated shares at a glance

Information last updated 2021-07-09.
Previous close$133.87
Change %0.874%
Information last updated 2022-01-17.
52-week range$111.8094 - $174.16
50-day moving average$156.6408
200-day moving average$143.8363
Wall St. target price$169.07
PE ratio8.5553
Dividend yield$2.42 (1.74%)
Earnings per share (TTM)$16.633

Do Quest Diagnostics Incorporated shares pay dividends?


Dividend yield: 1.74% of stock value


Forward annual dividend yield: 1.74% of stock value


Dividend payout ratio: 16.12% of net profits

Quest Diagnostics Incorporated has recently paid out dividends equivalent to 1.74% of its share value annually.

Quest Diagnostics Incorporated has paid out, on average, around 16.12% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.74% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 1.74% return on their shares, in the form of dividend payments. In Quest Diagnostics Incorporated's case, that would currently equate to about $2.42 per share.

While Quest Diagnostics Incorporated's payout ratio might seem low, this can signify that the company is investing more in its future growth.

Quest Diagnostics Incorporated's most recent dividend payout was on 2 February 2022. The latest dividend was paid out to all shareholders who bought their shares by 18 January 2022 (the "ex-dividend date").

Share price volatility

Over the last 12 months, Quest Diagnostics Incorporated's shares have ranged in value from as little as $111.8094 up to $174.16. A popular way to gauge a stock's volatility is its "beta".

DGX.US volatility(beta: 1.02)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Quest Diagnostics Incorporated's is 1.0218. This would suggest that Quest Diagnostics Incorporated's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site